American Gene Technologies International, based in Rockville, MD, is a clinical-stage biotechnology company focused on harnessing the power of gene therapy to develop innovative treatments for serious diseases. With a strong emphasis on gene and cell therapy, the company aims to provide potential functional cures for HIV and develop therapies for monogenic disorders and cancers.
Addimmune, a spinoff company of American Gene Technologies, is solely dedicated to finding a cure for HIV through gene and cell therapy. By building upon the success of American Gene Technologies' Phase 1 HIV clinical trial, Addimmune aims to accelerate the development of a potential cure for HIV, offering hope for those living with this lifelong illness.
Generated from the website